Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
A Study of Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer
ClinicalTrials.gov study NCT01851746. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BEACON - ABC in Recurrent Platinum Resistant HGSOC
ClinicalTrials.gov study NCT03363867. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Apatinib Combined With Letrozole With or Without Fluzoparib in Estrogen Receptor-Positive, Platinum-Sensitive Recurrent Ovarian Cancer Previously Treated With First-Line PARP Inhibitor
ClinicalTrials.gov study NCT07000344. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
ClinicalTrials.gov study NCT06434610. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-
ClinicalTrials.gov study NCT05925530. IPD Sharing: YES. Countries: 11. Publications: 0.
Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment
ClinicalTrials.gov study NCT04875611. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based Chemotherapy
ClinicalTrials.gov study NCT02152059. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT06990503. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel
ClinicalTrials.gov study NCT00313456. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TIPS for Platinum-Related Porto-Sinusoidal Vascular Disease With Variceal Bleeding
ClinicalTrials.gov study NCT06635122. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum-based Chemotherapy: A Randomized,Open Labled, Phase II C
ClinicalTrials.gov study NCT04513301. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT06973421. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
ClinicalTrials.gov study NCT07106762. IPD Sharing: YES. Countries: 22. Publications: 0.
Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens
ClinicalTrials.gov study NCT00610792. IPD Sharing: Not stated. Countries: 2. Publications: 0.
ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
ClinicalTrials.gov study NCT04055649. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer
ClinicalTrials.gov study NCT00059618. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NIVolumab in Subjects With Recurrent or Metastatic Platinum-refrACTORy SCCHN
ClinicalTrials.gov study NCT05802290. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers
ClinicalTrials.gov study NCT03567642. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy
ClinicalTrials.gov study NCT01039155. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum
ClinicalTrials.gov study NCT00189371. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.